Skip to main content
. 2016 Oct 18;173(23):3292–3306. doi: 10.1111/bph.13616

Figure 2.

Figure 2

SLC6A14 mRNA and protein expression is up‐regulated in pancreatic cancer. (A) Comparison of SLC6A14 mRNA levels between primary pancreatic cancer tissues and patient‐matched adjoining normal tissues (normal, n = 3; tumour, n = 3). (B) Comparison of SLC6A14 mRNA levels between primary pancreatic cancer tissues and unmatched normal pancreatic tissues (normal, n = 3; tumour, n = 3). (C) SLC6A14 mRNA levels in non‐malignant pancreatic cell lines versus pancreatic cancer cell lines. (D) SLC6A14 mRNA expression in pooled normal versus cancer cell lines (normal cell lines, n = 2; cancer cell lines, n = 6). (E) Western blotting analysis of SLC6A14 protein in normal versus cancerous pancreatic cell lines. (F) SLC6A14 mRNA levels in patient‐derived xenografts (PDXs). (G) SLC6A14 mRNA expression in pooled PDXs (normal tissue, n = 6; tumour tissue, n = 10). Data are given as means ± SEM. * P < 0.05.